Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Finasteride and minoxidil work best together for hair loss.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

AR gene not major factor in female hair loss; different from male hair loss.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Many lupus patients experience hair loss, which is linked to anxiety and other skin issues.

People with alopecia areata may have a higher risk of blood clots.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Patients need better information about the risks of long-term steroid use.

RDW can be a useful marker for inflammation in alopecia areata patients.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Alopecia areata treatment varies, with no optimal method established yet.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.